Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial

IMPORTANCE: An alternative option to maternal vaccination to prevent severe pertussis in infants is vaccination at birth. Data are needed on the immunogenicity and safety of a birth dose of monovalent acellular pertussis (aP) vaccine. OBJECTIVE: To compare IgG antibody responses to vaccine antigens...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, Nicholas, Nolan, Terry, Marshall, Helen, Richmond, Peter, Gibbs, Emma, Perrett, Kirsten, McIntyre, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248137/
https://www.ncbi.nlm.nih.gov/pubmed/30208475
http://dx.doi.org/10.1001/jamapediatrics.2018.2349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248137/
https://www.ncbi.nlm.nih.gov/pubmed/30208475
http://dx.doi.org/10.1001/jamapediatrics.2018.2349

Ejemplares similares